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Abstract 24 
 25 
Cephalic phase responses (CPR) are important in early initiation of digestion and maximal 26 
absorption of nutrients prior to ingestion. Bypassing CPR has been shown to have consequences 27 
on metabolic responses that may influence satiety. The aim of this study was to investigate if 28 
using gastric intubation to bypass oro-pharyngeal and oesophageal exposure would reduce CPR 29 
including insulin and blood glucose and whether these impact on gastric emptying and satiety. 30 
Ten male subjects were tested on 2 occasions, 3-7 days apart after an overnight fast, in 31 
randomized order. Subjects were cannulated and intubated with a gastric tube for both tests. For 32 
test one, subjects ate 400ml soup with a spoon and for test two the soup was infused into the 33 
stomach at an equivalent rate. Subsequently measurements of glycaemic (GR) and insulinaemic 34 
responses (IR) from cannula samples, breath samples for measurement of gastric emptying using 35 
the [13C] sodium acetate breath test and visual analogue scales (VAS) for satiety were taken over 36 
180 minutes. There were differences in IR over the first 15 minutes (Oral: 169.0 ± 22.1; Gastric 37 
124.1 ± 18.8; t(9)=2.67; p= 0.028) but no difference in GR. There were differences in gastric 38 
emptying half time (Oral:  85.0 ± 2.7 ; Gastric  79.4 ± 3.3; t(9)= 2.40; p=0.04) and ascension 39 
time (Oral: 68.2 ± 2.2; Gastric 64.0 ± 2.2 ; t(9)=2.57; p=0.03) with food taking longer to empty 40 
from the stomach on the Oral test day than on the Gastric test day. There was no significant 41 
difference in the satiety ratings. This study demonstrated that bypassing oro-pharyngeal and 42 
oesophageal exposure decreases the normal physiological CPR with detriment to IR and gastric 43 
emptying. 44 
 45 
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Introduction 47 
 48 
Oral ingestion of food and beverages provides a sensory experience including anticipation, sight, 49 
smell, chewing and taste. Bypassing this route removes much of this sensory stimulation and 50 
therefore reduces the normal physiological cephalic phase responses (CPR). These responses 51 
assist in early initiation of digestion and maximal absorption of nutrients prior to ingestion [1-3]. 52 
One response of particular interest is the CPR secretion of insulin (CPIR) and its role within 53 
glycaemic control [4-8]. Oral stimulation by food initiates fast release of insulin; that peaks 54 
between 1-4 minutes returning to baseline within ten minutes, the consequence of which avoids 55 
both peak levels of glucose release and subsequent gluconeogenesis and lipolysis [1, 3, 9].  56 
 57 
Work by Teff [10] identified that CPIR caused a 30% reduction in plasma glucose post ingestion 58 
of food and Ahren and Holst [6] found that blocking neural pathways for CPR caused a reduction 59 
of 73% in CPIR, causing higher plasma glucose levels for longer following food ingestion. 60 
Western diets currently contain more energy dense foods with less fibre [11]. These foods may 61 
reduce oroosensory stimulation as they need less chewing and have a faster oral transit time [8]. 62 
This can result in a reduction in both CPRs and satiety [8, 12].  With the loss of oral sensory 63 
stimulation and associated CPIR an individual’s risk of hyperglycaemia and hyperinsulinaemia is 64 
believed to be increased, and if this becomes a consistent metabolic profile there is a greater risk 65 
of subsequent metabolic and cardio-vascular disease [12, 13]. To date, many of the studies have 66 
focused on looking at the effect on glycaemic and insulinaemic responses directly following 67 
sham feeding or oral stimulation feeding [14-16] for up 30 min  but have not examined the 68 
impact of the CPIR on the entire postprandial period to demonstrate if they would present greater 69 
metabolic risk. 70 
 71 
Smeets et al. [8] believes that a loss of adequate oral sensory signalling from dietary choices that 72 
are more readily available in western society today are responsible for a reduction in satiety. 73 
Earlier work by Cecil et al. [14] identified that it is a combination of early oro-sensory 74 
stimulation with gastro-intestinal influences such as motility and distension that provides the 75 
greatest sensation of satiety. Furthermore utilising techniques that bypass oral CPR was found to 76 
increase rates of gastric emptying and decrease satiety [14].  Increasing rates of gastric emptying 77 
is likely to impact on satiety as food will remain in the stomach for a shorter time, decreasing the 78 
time that the stomach remains distended which could result in increased food consumption [14, 79 
17]. 80 
 81 
Although there is much evidence that the loss of CPIR impacts on the metabolic profile of an 82 
individual there is some contradiction within the evidence [3-6, 8, 13]. Only recently have 83 
studies combining sensory signals and the implications on food consumption been undertaken 84 
[16]. Smeets et al. [8] identifies a need for further work to examine the impact of sensory signals 85 
on both short term metabolic pathways and satiety.  Previous work has primarily focused on the 86 
effect of CPR on satiety and gastric emptying [14, 15] or on the role of CPR on immediate 87 
insulinaemic responses (IR) and glycaemic responses (GR) [16] but has not looked at the 88 
responses of both over the entire postprandial period where it is more likely to have a metabolic 89 
implication. This study therefore aimed to examine two components of CPR in combination, 90 
which is lacking from the extant literature. The first component that was measured was the effect 91 
of oral stimulation on IR and GR. The second component measured was changes in gastric 92 
emptying and satiety.   93 
 94 
Materials and Methods 95 
 96 
Subjects 97 
Twelve healthy males not suffering from diabetes or pre-diabetes were recruited for the study by 98 
means of advertisements and personal communications. Volunteers were given full details of the 99 
study protocol prior to giving their written informed consent. Ethical approval for this study was 100 
provided by the Research Officer for Faculty of Health and Life Sciences, Oxford Brookes 101 
University, UK, in accordance with the Declaration of Helsinki. All subject’s fasting blood 102 
glucose was <6.1mmol/l and their BMI was between 18.5 - 30kg/m2. None of the subjects were 103 
taking any medication that would interfere with glucose metabolism or insulin signalling. None 104 
of the participants were smokers. Eating behaviour was determined using the Three Factor 105 
Eating Questionnaire [18]. Only those who did not consciously restrain their food intake due to 106 
psychological reasons, weight concerns and external stimuli were included in the study. All 107 
subjects were asked to rate their liking of the soup on a scale of 1-10 with 1 being strongly 108 
disliking it. All volunteers reported liking the soup and rated it as 7 or greater and hence were 109 
included in the study. 110 
 111 
Study Design 112 
The study required volunteers to attend the lab on three separate occasions. The first was for 113 
initial preliminary assessment and if volunteers were suitable to proceed with the study they were 114 
required to attend for two subsequent test days; one consisting of oral ingestion of soup (Oral) 115 
and one consisting of gastric infusion of the soup into the stomach via a feeding tube (Gastric). 116 
The two tests days were carried out in random order, with a minimum of three, maximum seven 117 
days between tests.  118 
 119 
Subjects were requested to record their food intake in a weighed food diary the night before 120 
attending for their first test and repeat this prior to their second test. They were requested to fast 121 
from 22.00 the night before although were able to drink water. Subjects were also requested to 122 
abstain from strenuous exercise and alcohol consumption the day before testing.  123 
 124 
Preliminary assessment 125 
Volunteers were requested to attend the lab after an overnight fast so a fasting blood glucose 126 
measurement could be taken via a fingerprick blood sample (HemoCue 201+ glucose analyzer, 127 
Angelholm, Sweden). A health questionnaire pertaining to food allergies and intolerances and 128 
any known metabolic conditions or medication was requested. Baseline anthropometric 129 
measurements of height, weight, body mass index (BMI) and blood pressure were undertaken 130 
from each individual subject. These aimed to screen for any medical conditions or medication 131 
that may interfere with glucose metabolism or insulin signalling; in which case the volunteer 132 
would be declined from participating further within the study.  133 
 134 
The preliminary test required volunteers to attempt insertion of an oral gastric feeding tube 135 
(Vygon, 14 French Levine, length 125, Gastro-duodenal feeding tube, Ecouca, France). This 136 
ensured volunteers could satisfactorily undertake the procedure and familiarise themselves with 137 
the technique. Self-insertion of the tube makes the process less stressful for the volunteer as it 138 
gives them control over the rate of insertion [19]. Tube insertion was required to a length of 50-139 
55 cm and subjects needed to retain the tube placement comfortably. For subjects having 140 
difficulty, repeated attempts were not encouraged as this can impact on the gastric response.  141 
Accurate placement of the tube was confirmed by inserting 100ml of water and using a 100ml 142 
syringe to aspirate the gastric contents. Once 80% of this can be aspirated then the tube was 143 
deemed to be in the stomach [20]. The gastric tube was then removed. Following preliminary 144 
testing, two volunteers were unable to pass the oral gastric tube (gastric intubation) and 145 
withdrew, leaving a subject group of 10 male participants (37.8±3.4 years; 1.77±0.03m; 146 
75.4±4.2kg). 147 
 148 
Subjects who were able to proceed with the study were then timed whilst ingesting 400ml of the 149 
test soup orally in order to measure the rate of normal feeding. This allowed determination of an 150 
individual flow rate in ml/min for gastric tube infusion of the soup using a syringe during the 151 
Gastric test session. 152 
 153 
Experimental Test Protocol. 154 
Subjects attended the lab in the morning between 7-8am after an overnight fasting. On arrival, 155 
cannulation of a superficial vein of the upper limb was undertaken to provide collection of blood 156 
samples for glucose and insulin measurement throughout the test protocol. Samples were taken at 157 
a baseline of – 5 minutes, following the onset of soup ingestion / infusion at 3 minute intervals 158 
for first 15 minutes and then subsequently at 15 minute intervals for a total of 180 minutes. 159 
Baseline assessment of satiety using 100mm visual analogue scale (VAS) and breath samples for 160 
measurement of gastric emptying were also undertaken at -5 minutes.  161 
 162 
Subjects inserted the oral gastric tube for both the Oral and the Gastric test in order to ensure 163 
there was no physiological difference between circumstances of each test that may influence 164 
findings. The oral gastric tube was removed by the subjects after completion of the first 15 165 
minutes of the trial. 166 
 167 
The 400ml of test soup was ingested orally by the subject or infused via the oral gastric tube at 168 
the rate of normal eating as determined from the pre-test trial. The test meal and quantity were 169 
based on previous similar studies [14, 15]. Timing of each test trial began at the point of 170 
initiating food eating / infusion. The test soup (Campbell’s Cup Soup, Cream of tomato, Leeds, 171 
UK) contained 25g of available carbohydrate and had 100mg of [13 C] labelled sodium acetate 172 
added. This is a naturally stable carbon isotope which is rapidly absorbed and oxidised within the 173 
liver to form labelled CO2 which subjects then exhale. The soup contained 170 kcal, 2.5g 174 
protein, 28.3g total carbohydrate, 4.9 g fat and 0.7g sodium. The soup was prepared by adding 175 
the soup powder to 300 ml of boiling water, 100 ml of water at room temperature and serving or 176 
intubating immediately. 177 
 178 
Gastric emptying 179 
Collection of breath via a straw tube into a glass vial (10ml Exetainer, Labco, Bucks, UK) allows 180 
analysis at a later stage as an indicator of the rate of gastric emptying. Work by Braden et al. [21] 181 
identified that this non-invasive method is reliable, safe and cost-effective for measuring rates of 182 
gastric emptying.  Subject’s breath samples were taken at baseline of -5 minutes, postprandial at 183 
3,6,9,12,15 minutes and then every 15 minutes until 180 minutes. Samples were then analysed 184 
using isotope ratio mass spectrometry (ABCA, SerCon Limited, Crewe, UK) and results were 185 
expressed relative to V-PDB, an international standard for known 13C composition. For breath 186 
13CO2 levels using 130 known standard samples, the coefficient of variation across these samples 187 
has been shown to be 0.0044% [22]. 13CO2 values were expressed as the excess amount in the 188 
breath above baseline and converted into moles. Data are then displayed as percentage of 13CO2 189 
dose recovered per hour and cumulative percentage 13CO2 recovered over time. CO2 production 190 
was assumed to be 300 mmol/m2 body surface area per hour.  Body surface area was calculated 191 
using a validated weight-height formula [23]. This was then fitted to a gastric emptying model 192 
developed by Ghoos et al., [24]. For all the data, r2 coefficient between the modelled and raw 193 
data was calculated and r2>0.95. From this model several parameters were measured. Lag phase 194 
and half time were calculated using the formulae derived by Ghoos et al., [24]. Lag phase is the 195 
time taken to maximal rate of 13CO2 excretion [25] and is equivalent to the time of the inflection 196 
point [26]. Half time is the time it takes 50% of the 
13C dose to be excreted [25]. Latency phase 197 
[26] is the point  of intersection of the tangent at the inflection point of the 13CO2 excretion curve 198 
representing an initial delay in the excretion curve.  Ascension time [26] is the time course 199 
between the latency phase and the half time representing a period of high 13CO2-excretion rates.   200 
 201 
Blood glucose 202 
Blood samples were used to test for blood glucose and insulin at each time point. Blood glucose 203 
was measured using the HemoCue® 201+ Glucose analyzer (HemoCue Ltd, Dronfield, UK). The 204 
HemoCue® is a reliable method of blood glucose analysis [27].  The laboratory's CV for 20 or 205 
more duplicate measurements of fasting glucose (i.e. minute-to-minute variation in human 206 
subjects) was <5%.  The inter-assay CV (i.e. analytical variation) on standard solutions was 207 
<3.6%. 208 
 209 
Insulin  210 
At each time point, 6 mL was collected into blood collection tubes treated with di Potassium 211 
EDTA (BD vacutainer, Oxford, UK) and immediately stored in crushed ice. Samples were then 212 
centrifuged 4000rpm, 4 ºC, for 10 minutes. Plasma was removed and stored at -40 ºC until 213 
analysis. Insulin concentrations in the plasma samples were determined by 214 
electrochemiluminescence immunoassay using an automated analyzer (Cobas® E411; Roche 215 
diagnostics, Burgess Hill, UK).  The Cobas® system is a reliable method of blood insulin 216 
determination [28]. The unit of measurement was μU/ml.  217 
 218 
On completion of the 180 minutes testing, the subject’s intra–venous cannula was removed. 219 
 220 
Visual analogue scales 221 
Throughout the test trials 100mm visual analogue scale (VAS) were utilised by each subject; at 222 
baseline, 6, and 15 minutes and then every subsequent 15 minutes for a total of 180 minutes in 223 
order to gain some comparison between oral ingestion and gastric infusion on their desire to eat 224 
and level of satiety.  Each time point required subjects to make a vertical mark across the 225 
horizontal VAS line with anchor points of ‘not at all to ‘extremely’ for  specific questions to rate 226 
their level of hunger, fullness and desire to eat and anchor points of ‘nothing at all’ to ‘large 227 
amount’ for how much food they thought they could eat.  Use of VAS as a reliable measure of 228 
subjective appetite and predictability of feeding behaviour is validated by Sorensen et al. [29].  229 
 230 
Statistical analysis 231 
Results of blood glucose, insulin and VAS data were converted to reflect the change in GR, IR 232 
and VAS respectively by subtracting the baseline value from those taken at set time points. It 233 
was this change response value that was then used within all subsequent analysis. Incremental 234 
area under the curve (IAUC) using the trapezoidal rule [30] was calculated for all  GR, IR and 235 
the four parameters of the VAS. GR and IR IAUC were calculated for the first 15 min of the test, 236 
the first 60 min of the test and the entire 180 in of the test. Statistical analysis was undertaken 237 
using Statistical Package for Social Sciences (SPSS, version 19.0, USA).  Mean differences 238 
between Oral and Gastric IAUC for total GR, IR and the four parameters of the VAS were 239 
analyzed using paired sample t-test and the effect size as calculated using Cohen’s d. Paired 240 
sample t-test was also used for comparison of gastric emptying times. Results are expressed as 241 
means ± standard error (SE) unless otherwise stated and significance was defined as p<0.05. 242 
 243 
Results 244 
 245 
Glycaemic Response 246 
During the 180 minute test the GR peaked at 30 minutes in both Oral (2.35±0.25 mmol/L) and 247 
Gastric (2.76±0.35 mmol/L) tests (Figure 1). In both tests, this peak was followed by a rapid 248 
decline in glucose concentration with the nadir occurring at 75 minutes in the Oral test (-249 
1.25±0.19 mmol/L) and in the Gastric test (-1.41±0.29 mmol/L). There was no significant 250 
difference in the peak GR between the tests (t(9)=1.13; p=0.29; d=0.50). 251 
 252 
There were no significant differences in GR IAUC following either 180 min (Oral: 71.3±9.5 253 
mmol/L·min; Gastric 79.7±12.7 mmol/L·min; t(9)=0.68; p=0.51; d=0.24), 60 min (Oral: 254 
64.9±9.5 mmol/L·min; Gastric 74.7±10.4 mmol/L·min; t(9)=0.78; p=0.45; d=0.04) or 15 min 255 
(Oral: 6.0±1.2 mmol/L·min; Gastric 6.1±1.7 mmol/L·min; t(9)=0.11; p=0.91; d=0.31). 256 
 257 
Insulinaemic response 258 
Over 180 minutes the IR (Figure 2) peaked at 30 minutes in both Oral (51.8±8.1 uU/ml) and 259 
Gastric (62.9±8.1 uU/ml) tests with a nadir at 165 minutes for Oral (-0.5±0.5 uU/ml) and at 135 260 
minutes for Gastric (-1.2±0.3 uU/ml).  There was no significant difference in the peak IR 261 
between the tests (t(9)=1.23; p=0.25; d=0.38). 262 
 263 
There were no significant differences in IR AUC following 180 min (Oral: 1897.7±309.2 264 
uU/ml·min; Gastric 2037.5±205.9 uU/ml·min; t(9)=0.61; p=0.56; d=0.19) or 60 min (Oral: 265 
1638.7±262.0 uU/ml·min; Gastric 1870.5±196.8 uU/ml·min; t(9)=1.10; p=0.30; d=0.36) but 266 
there was a difference after 15 min, with the Oral test causing the greater IR (Oral: 169.0±22.1 267 
uU/ml·min; Gastric 124.1±18.8 uU/ml·min; t(9)=2.67; p=0.028; d=0.63). 268 
 269 
Gastric emptying 270 
There were significant differences in gastric emptying times between the meals for half time 271 
(t(9)= 2.40; p=0.04) and ascension time (t(9)=2.57; p=0.03) but not for latency or lag phase 272 
(p>0.05). The food took ~4-5 min longer to empty from the stomach on the Oral test day than on 273 
the Gastric test day (Table 1) 274 
 275 
Satiety 276 
There were no significant differences in satiety ratings following the two different feeding 277 
methods for any of the parameters hunger (t(9)=0.38; p=0.71), fullness (t(9)=0.96; p=0.36), 278 
desire to eat (t(9)=1.60; p=0.15) and prospective consumption (t(9)=0.68; p=0.52) (Table 2; 279 
Figure 3). 280 
 281 
Discussion 282 
 283 
This study was the first to examine the entire IR and GR postprandial profile in combination with 284 
GR and satiety following Oral and Gastric feeding. The study demonstrated no significant 285 
differences between oral or intubated feeding on GR however the Oral method of feeding 286 
resulted in a greater IR over the first 15 minutes. There were also no significant differences 287 
found between Oral or Gastric feeding on satiety but gastric emptying was significantly 288 
accelerated by 4-5min on the Gastric test in comparison to the Oral test.  289 
 290 
In comparing oral ingestion with intubated feeding it was hypothesised within the present study 291 
that bypassing oro-pharyngeal and oesophageal exposure would decrease the CPIR [31]. 292 
Findings from this present study based on the first 15 min of IAUC insulin data appear to 293 
replicate the characteristic early CPIR profile reported in previous work from oral ingestion of 294 
food [10]. However there were no differences in GR between the oral ingestion compared with 295 
intubated feeding. Early CPIR occurs to a peak within the initial 1- 4 minutes after gustatory 296 
stimulation returning to baseline within ten minutes [1-3, 9, 32]. Although overall it is a minimal 297 
rise in insulin concentration levels compared to those secreted postprandially (5uU/ml [5] for 298 
cephalic response compared to a postprandial response that could be ~60 uU/ml (current study)), 299 
it is believed to increase digestive secretions, decrease gut motility and decrease food intake [1-300 
3].  301 
 302 
The effects of CPIR on blood glucose appear to differ. Findings in a study by Teff et al. [32] 303 
identified that in normal weight healthy males, 4 minutes post ingestion of food there was a 304 
significant increase in insulin and also a significant drop in plasma glucose as a result of early 305 
CPIR. However as in the current study, this change in GR has not been replicated in all studies 306 
perhaps due to difficulty in measuring such small variations in blood samples [5, 8]. Ranawana 307 
et al. [33] also identified high variability in glucose absorption between individuals even after 308 
eating the same food. This presents some evidence that within-individual variance is also a 309 
possibility even in a controlled methodology which may account for the lack of differences seen 310 
here. A further consideration is that simultaneous release of glucagon during CPR may prevent a 311 
reduction in blood glucose levels caused by CPIR [5] but without measuring glucagon levels this 312 
is an unknown factor in the present study.  313 
 314 
Other reasons for disparity within the results of studies on CPR maybe palatability and the 315 
duration of oral transit time [8]. To date there is mixed findings as to whether palatability 316 
directly impacts vagally activated pathways to increase concentrations of CPIR; which may 317 
influence study findings if there is inconsistency within the subject group [9, 29, 34]. However 318 
within the present study an initial questionnaire undertaken identified that none of the subjects 319 
had a dislike for the tomato soup, utilised. Expert opinion is also divided in relation to the effect 320 
the texture or form of food choice may have on oral exposure time. Teff [34] believes there is a 321 
lack of CPIR to liquid stimuli; suggesting that chewing is required for adequate vagal stimulation 322 
for insulin secretion. However, Cecil et al. [14, 15, 35] validate the use of liquid soup for 323 
initiating CPR where they found the influence of sight, smell, and taste played an important part 324 
in stimulating both pancreatic and gastric secretions as well as influencing appetite regulatory 325 
centres. Cassady et al. [36] and deGraaf [12] also identify that liquid such as soup when eaten 326 
with a spoon extends oro-sensory transit time to increase both CPR and satiety. A final 327 
explanation for the differences in results seen between studies may come from work by Cecil et 328 
al. [15], who found that the macronutrient content of the soup plays an important role as high fat 329 
soup suppressed hunger, induced fullness, and slowed gastric emptying more than the high-330 
carbohydrate soup when ingested orally but there was no differences between the soups when 331 
they were given intragastically.   332 
 333 
One of the main aims of the current research was to combine satiety and metabolic responses 334 
within the one study. Oro-sensory stimulation has been shown to increase the secretion of gastro-335 
intestinal peptides, these peptides slow gastric emptying [5, 34]. The delay in gastric emptying 336 
increases satiety by prolonging stomach distention [8, 14, 31]. The present study hypothesised 337 
that bypassing oro-pharyngeal and oesophageal exposure would reduce levels of satiety by 338 
reducing the insulinaemic response and accelerating gastric emptying. Bypassing oro-pharyngeal 339 
and oesophageal exposure did result in a slight acceleration in gastric emptying and increased 340 
insulinaemic response however it was not possible to detect any differences from this in satiety. 341 
A recent study [16] was able to confirm that gastric infusion of nutrients induced greater appetite 342 
ratings than ingestion, alongside increases in satiety hormones however they were unable to 343 
detect changes in food intake. Cecil et al. [14, 15, 35] also utilised gastric intubation in a series of 344 
studies assessing the impact of bypassing oro-pharyngeal stimulation on satiety and gastric 345 
emptying. They identified that loss of oro-sensory stimulation impacted negatively on both 346 
satiety and gastric emptying, with subjects feeling fuller earlier with greater suppression of 347 
hunger when food was eaten orally. The present study failed to find significant differences 348 
between the tests for satiety; this may be due to the gastric emptying changes of only 4-5 min, 349 
which although significant may not be sufficient to decrease satiety. It may also be due to the 350 
large variability on the VAS data. However it should be noted that VAS assessments are only a 351 
measure of perceived hunger not actual food intake and an ad libitum test meal would have 352 
provided objective assessment of subsequent food intake [36, 37]. Although other studies have 353 
been able to identify changes in VAS with oral stimulation using a similar sample size they have 354 
not been able to detect changes in actual food intake [16].  An increased sample size however is 355 
hindered by the invasive nature of the intubation test procedure. 356 
 357 
Conclusion 358 
 359 
In conclusion this study was able to demonstrate that utilising an oral gastric tube for infusion of 360 
food to bypass oro-pharyngeal and oesophageal exposure decreases the normal physiological 361 
CPR with detriment to IR and marginal accelerations in gastric emptying but was unable to 362 
demonstrate any impact on satiety and GR. Potential future research could use a solid test meal 363 
and include an ad libitum test meal. 364 
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Figure 1. Change in blood glucose response (mean ± standard error) following Oral and Gastric 483 
tests over 180 minutes (a) and over 15 minutes (b). 484 
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Figure 2. Change in insulinaemic response (mean ± standard error) following Oral and Gastric 509 
tests over 180 minutes (a) and over 15 minutes (b). 510 
a) 511 
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Figure 3. Change in satiety ratings from visual analogue scales (mean ± standard error) following 518 
Oral and Gastric tests for hunger (a), fullness (b), desire to eat (c) and prospective consumption 519 
(d). 520 
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Table 1: Gastric emptying times (mean ± standard error) following Oral and Gastric infusion of 536 
soups. *=p<0.05 537 
Time Oral Gastric d 
Latency Phase 
(min) 
16.8 ± 0.7 15.4 ± 1.3 0.44 
Lag phase (min) 52.4 ± 1.8 48.4 ± 2.8 0.55 
Half time (min) 85.0 ± 2.7 79.4 ± 3.3* 0.59 
Ascension time 
(min) 
68.2 ± 2.2 64.0 ± 2.2* 0.60 
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 553 
Table 2: Satiety rating, hunger, fullness, desire to eat and prospective consumption (mean ± 554 
standard error) following Oral and Gastric infusion test. 555 
  Oral  Gastric d 
Hunger (mm.min) 1914 ± 489 2298 ± 731 0.20 
Fullness (mm.min) 3964 ± 711 3330 ± 808 0.26 
Desire to eat (mm.min) 1149 ± 712 2050 ± 802 0.38 
Prospective consumption 
(mm.min) 
1680 ± 621 2233 ± 848 0.24 
 556 
